Structure-guided combination therapy to potently improve the function of mutant CFTRs
出版年份 2018 全文链接
标题
Structure-guided combination therapy to potently improve the function of mutant CFTRs
作者
关键词
-
出版物
NATURE MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-27
DOI
10.1038/s41591-018-0200-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutation-specific downregulation of CFTR2 variants by gating potentiators
- (2017) Radu G Avramescu et al. HUMAN MOLECULAR GENETICS
- Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations
- (2017) Robert M. Vernon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
- (2017) Xuefeng Liu et al. Nature Protocols
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
- (2017) Jennifer L. Taylor-Cousar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell
- (2017) Miklos Bagdany et al. Nature Communications
- Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
- (2017) Iwona M. Pranke et al. Scientific Reports
- A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
- (2016) A Tosco et al. CELL DEATH AND DIFFERENTIATION
- Analysis of nasal potential in murine cystic fibrosis models
- (2016) Mélanie Faria da Cunha et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
- (2016) Gudio Veit et al. MOLECULAR BIOLOGY OF THE CELL
- Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy
- (2016) Justin D. Hall et al. PROTEIN SCIENCE
- Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect
- (2016) Guido Veit et al. PLOS BIOLOGY
- Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27
- (2015) Miquéias Lopes-Pacheco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Restoration of NBD1 Thermal Stability Is Necessary and Sufficient to Correct ∆F508 CFTR Folding and Assembly
- (2015) Lihua He et al. JOURNAL OF MOLECULAR BIOLOGY
- RNA Interference Screen to Identify Kinases That Suppress Rescue of ΔF508-CFTR
- (2015) Agata M. Trzcińska-Daneluti et al. MOLECULAR & CELLULAR PROTEOMICS
- ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis
- (2015) Sandra Pankow et al. NATURE
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unravelling druggable signalling networks that control F508del-CFTR proteostasis
- (2015) Ramanath Narayana Hegde et al. eLife
- Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508–CFTR Protein Trafficking
- (2014) Keith C. Coffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis
- (2014) D. M. Cholon et al. Science Translational Medicine
- Modulation of the Maladaptive Stress Response to Manage Diseases of Protein Folding
- (2014) Daniela Martino Roth et al. PLOS BIOLOGY
- Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction
- (2013) Carlos M. Farinha et al. CHEMISTRY & BIOLOGY
- Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function
- (2013) Fredrick Van Goor et al. Journal of Cystic Fibrosis
- Ubiquitination-dependent quality control of hERG K+ channel with acquired and inherited conformational defect at the plasma membrane
- (2013) Pirjo M. Apaja et al. MOLECULAR BIOLOGY OF THE CELL
- VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
- (2013) Hong Yu Ren et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
- (2013) Emilie Lyne Saussereau et al. PLoS One
- The CFTR Ion Channel: Gating, Regulation, and Anion Permeation
- (2013) T.-C. Hwang et al. Cold Spring Harbor Perspectives in Medicine
- Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
- (2012) Juan L. Mendoza et al. CELL
- Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
- (2012) Wael M. Rabeh et al. CELL
- CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity
- (2012) S. Monterisi et al. JOURNAL OF CELL SCIENCE
- Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
- (2012) Guido Veit et al. MOLECULAR BIOLOGY OF THE CELL
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Protein quality control at the plasma membrane
- (2011) Tsukasa Okiyoneda et al. CURRENT OPINION IN CELL BIOLOGY
- V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists
- (2011) Kazuhiro Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small-molecule proteostasis regulators for protein conformational diseases
- (2011) Barbara Calamini et al. Nature Chemical Biology
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Ca2+-activated Cl− channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea
- (2010) Wan Namkung et al. FASEB JOURNAL
- CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners
- (2010) Chunying Li et al. Integrative Biology
- The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis
- (2010) Patrick H. Thibodeau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quality control for unfolded proteins at the plasma membrane
- (2010) Pirjo M. Apaja et al. JOURNAL OF CELL BIOLOGY
- Correction of the Phe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
- (2010) R. Robert et al. MOLECULAR PHARMACOLOGY
- Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
- (2010) T. Okiyoneda et al. SCIENCE
- Cooperative Assembly and Misfolding of CFTR Domains In Vivo
- (2009) Kai Du et al. MOLECULAR BIOLOGY OF THE CELL
- Solubilizing Mutations Used to Crystallize One CFTR Domain Attenuate the Trafficking and Channel Defects Caused by the Major Cystic Fibrosis Mutation
- (2008) Luísa S. Pissarra et al. CHEMISTRY & BIOLOGY
- Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects
- (2008) A. Duarri et al. HUMAN MOLECULAR GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More